Is Wysa anonymous?

Is Wysa anonymous?

Wysa app lets users chat anonymously and can be accessed through the app, online or on WhatsApp 24/7, when other help may not be available. People from more than 30 countries across the world from many age groups talk to Wysa. Wysa is designed to help people who are experiencing low mood, stress or anxiety, or who are interested in improving their emotional resilience. Currently, Wysa has facilitated over 400 million conversations with 4.5 million users in 65 countries. Enter Wysa, a made in India app founded by Jo Aggarwal and Ramakant Vempati in 2015. “Wysa has not only been extremely successful as a consumer well-being platform but has also developed into a clinically validated, powerful tool to proactively manage mental health and well-being,” said Ramakant Vempati, co-founder, Wysa.

Is Wysa secure?

Again, that is very good. Consumer Reports did find in 2021 that Wysa shared some data with Facebook, but from what we can tell, that is likely not personal information. And all those AI chatbot conversations, Wysa says they will never share that data without user consent. Wysa was launched on World Mental Health Day in 2016. The startup uses an AI-powered conversational agent to help users manage their stressors with self-care tools and expert support. Conversational AI Therapy Startup Wysa Earns FDA Breakthrough Certification. Behavioral health conversational AI developer Wysa has scored Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). People from more than 30 countries across the world from many age groups talk to Wysa. Wysa is designed to help people who are experiencing low mood, stress or anxiety, or who are interested in improving their emotional resilience. Wysa was a side project – at that time the cofounders, Jo Aggarwal and Ramakant Vempati were building machine learning models to detect depression, using sensor feeds from the phone. The detection model worked technically – with a 90% accuracy – but only 1 in 30 people actually took help from a therapist. Wysa Revenue and Competitors Wysa’s total funding is $9.4M.

Where is Wysa based?

About Wysa The company was founded in 2015 and is based in Bengaluru India. Wysa employs 11 to 50 employees in India. The overall rating of Wysa is 5.0, with Skill development being rated at the top and given a rating of 5.0. Jo Aggarwal – Founder & CEO – Wysa | LinkedIn. Wysa’s top competitors include Woebot Health, SilverCloud Health, and Headspace. Woebot is an automated conversational agent (chatbot) who helps users monitor their mood and learn about themselves. Vempati told TechCrunch that about 80% of Wysa’s business comes from enterprise customers. “Enterprise and B2B will become increasingly more important going forward for both commercial growth as well as impact,” he said, adding that the B2C model has historically driven a majority of Wysa’s market impact. Today’s entrepreneur is Jo Aggarwal, co-founder and CEO of AI-powered mental health startup Wysa, which use a mix of humans and AI to treat patients.

Is Wysa a bot?

Wysa offers an AI chatbot that can guide users through cognitive behavioral therapy for concerns like low mood, anxiety and stress. The startup’s employer offering also includes a self-care library of exercises around self-esteem, sleep and mindfulness, as well as optional access to Wysa human coaches. Wysa offers an AI chatbot that can guide users through cognitive behavioral therapy for concerns like low mood, anxiety and stress. The startup’s employer offering also includes a self-care library of exercises around self-esteem, sleep and mindfulness, as well as optional access to Wysa human coaches. Wysa helps in dealing with stress, depression, and anxiety with the help of an “emotionally intelligent” bot, which uses evidence-based cognitive-behavioral techniques (CBT), meditation, breathing and mindfulness exercises, as well as micro-actions to help users build mental resilience skills. Conversational AI Therapy Startup Wysa Earns FDA Breakthrough Certification. Behavioral health conversational AI developer Wysa has scored Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).